Portfolio

Extensive Industry Coverage

Investments span across pharma, healthcare delivery, medical devices, animal health, nutraceuticals, and heathtech

Exceptional Track Record

35 Investments and 16 Realisations since inception – the highest in the Indian life sciences growth PE domain

Extraordinary Value Creation

Leveraging domain insights and operational experience, generated over 4-fold increase in EBITDA across portfolio companies
  • All
  • Fund I
  • Fund II
  • Fund III
  • Fund IV
ABI-Health
ABI Health
  • Fund IV·
Accumax
  • Fund III·
Aizant Drug Research Solutions Pvt. Ltd
  • Fund II·
Alniche Life Sciences Pvt Ltd
  • Fund II·
Anjan Drugs Private Limited
  • Fund I·
Ankura
  • Fund III·
Biorad Medisys
  • Fund II·
Comprehensive Prosthetics & Orthotics (CPO)
  • Fund II·
Dr. Agarwal’s Health Care
  • Fund I·
Enaltec Labs Pvt Ltd
  • Fund II·
fleminglabs
Fleming Laboratories
  • Fund IV·
Fermenta Biotech Limited
  • Fund I·
General Diagnostics
  • Fund III·
Gland Pharma
  • Fund I·
Health Care Global (HCG)
  • Fund I·
Intron
  • Fund III·
Inventia
  • Fund III·
Malladi
  • Fund III·
Medibuddy
  • Fund III·
Murli Krishna Pharma
  • Fund III·
Neuland Group
  • Fund I·
Oasis
  • Fund II·
Oliva Advanced Hair & Skin Clinic
  • Fund II·
Pregna
  • Fund III·
Relisys Medical Devices Limited
  • Fund II·
Sandor Medicaids Pvt Ltd
  • Fund II·
Sharp Sight
  • Fund III·
Stericon Pharma Pvt Ltd
  • Fund II·
Strides
  • Fund III·
Sunshine Hospitals
  • Fund II·
Sunways (India) Private Limited
  • Fund III·
Sutures India
  • Fund I·
Symbiotec
  • Fund III·
Synergia Life Sciences
  • Fund II·
Uquifa
  • Fund I·
Scroll to top